SGNI — StemGen Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro Cap

Annual cashflow statement for StemGen, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2017 June 30th	2018 June 30th	2019 June 30th	2020 June 30th	2021 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.07	0.006	-0.426	-0.231	-0.433
Depreciation
Non-Cash Items	0.001	-0.122	0.194	0.023	0.048
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.069	0.108	0.066	0.152	0.131
Change in Accounts Receivable
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	0	-0.008	-0.105	-0.037	-0.141
Capital Expenditures	—	—	0	0	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	—	—	0.022
Sale of Fixed Assets
Cash from Investing Activities	—	—	0	0	0.022
Financing Cash Flow Items	—	—	0.066	0.027	0.12
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0	0.007	0.088	0.034	0.12
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	-0.001	-0.017	-0.003	0.001